Items where authors include "Clare, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Sgrò, A., Blanco-Colino, R., Brindl, N. et al. (5363 more authors) (2025) Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study. British Journal of Surgery, 112 (3). znaf005. ISSN 0007-1323

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Sowerby, J., Thomas, D., Clare, S. et al. (18 more authors) (2017) Nbeal2 is required for neutrophil and NK cell function, and pathogen defence. Journal of Clinical Investigation, 127 (9). pp. 3521-3526. ISSN 0021-9738

Oshota, O., Conway, M., Fookes, M. et al. (11 more authors) (2017) Transcriptome and proteome analysis of Salmonella enterica serovar Typhimurium systemic infection of wild type and immune-deficient mice. PLoS ONE, 12 (8). e0181365. ISSN 1932-6203

Thomas, D. C., Clare, S., Sowerby, J. M. et al. (24 more authors) (2017) Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. Journal of Experimental Medicine, 214 (4). 1111. ISSN 0022-1007

Blohmke, C.J., Darton, T.C. orcid.org/0000-0003-2209-9956, Jones, C. et al. (24 more authors) (2016) Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever. Journal of Experimental Medicine, 213 (6). pp. 1061-1077. ISSN 0022-1007

Grant, A. J., Oshota, O., Chaudhuri, R. R. orcid.org/0000-0001-5037-2695 et al. (5 more authors) (2016) Genes Required for the Fitness of Salmonella enterica Serovar Typhimurium during Infection of Immunodeficient gp91 −/− phox Mice. Infection and Immunity, 84 (4). pp. 989-997. ISSN 0019-9567

Deakin, L.J., Clare, S., Fagan, R.P. et al. (7 more authors) (2012) The Clostridium difficile spo0A gene is a persistence and transmission factor. Infection and Immunity, 80 (8). 2704 - 2711.